Lukas Biomedical Inc. (TPEX:6814)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.85
-1.65 (-7.67%)
Aug 26, 2026, 1:51 PM CST

Lukas Biomedical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
26.8134.7564.7131.840.2664.81
Cash & Short-Term Investments
26.8134.7564.7131.840.2664.81
Cash Growth
-33.45%-46.31%103.50%-21.02%-37.88%66.00%
Accounts Receivable
12.4111.529.6810.6812.0918.25
Receivables
12.4111.529.6810.6812.0918.25
Inventory
41.2135.3938.0236.7342.426.89
Prepaid Expenses
12.589.1510.556.329.849.91
Other Current Assets
2.021.531.531.850.940.66
Total Current Assets
95.0392.33124.587.37105.53120.53
Property, Plant & Equipment
44.9158.5772.5275.4792.89123.51
Other Intangible Assets
0.240.27-0.030.090.2
Long-Term Deferred Tax Assets
--1.871.771.852
Other Long-Term Assets
333.83275.64277.62276.55279.31285
Total Assets
474.01426.8476.5441.19479.67531.24

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9.744.115.716.958.993.18
Accrued Expenses
-13.08----
Short-Term Debt
11565-5-90
Current Portion of Long-Term Debt
11.8611.7311.447.656.376.39
Current Portion of Leases
12.911.0713.5313.3812.6413.82
Current Unearned Revenue
1.091.041.581.5111.691.2
Other Current Liabilities
18.948.7924.6723.1616.7715.95
Total Current Liabilities
169.54114.8156.9357.6556.45130.54
Long-Term Debt
40.7546.7258.4669.9157.5363.82
Long-Term Leases
68.2321.5131.7729.9335.6947.27
Other Long-Term Liabilities
4.233.583.533.572.512.93
Total Liabilities
282.75186.62150.68161.06152.18244.57

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
418.74418.74418.74368.74368.74328.74
Additional Paid-In Capital
-90.0790.07-96.170.17
Retained Earnings
-227.48-268.62-182.99-88.61-137.43-87.36
Comprehensive Income & Other
-----45.12
Total Common Equity
191.26240.19325.82280.13327.49286.68
Shareholders' Equity
191.26240.19325.82280.13327.49286.68
Total Liabilities & Equity
474.01426.8476.5441.19479.67531.24

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
248.75156.02115.2125.86112.22221.31
Net Cash (Debt)
-221.94-121.27-50.49-94.06-71.96-156.5
Net Cash Growth
------
Net Cash Per Share
-5.29-2.90-1.28-2.55-1.96-4.76
Filing Date Shares Outstanding
41.8241.8741.8736.8736.8732.87
Total Common Shares Outstanding
41.8241.8741.8736.8736.8732.87
Working Capital
-74.51-22.4967.5729.7249.08-10.01
Book Value Per Share
4.575.747.787.608.888.72
Tangible Book Value
191.02239.91325.82280.1327.39286.48
Tangible Book Value Per Share
4.575.737.787.608.888.71
Buildings
-28.2728.2728.2728.2728.31
Machinery
-69.4261.8555.8653.8953.8
Leasehold Improvements
-5.467.127.267.2631.1